{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:52:49Z","timestamp":1761598369980,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T00:00:00Z","timestamp":1630972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007398","name":"Strategiske Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["0603-00479B","NCT02814474"],"award-info":[{"award-number":["0603-00479B","NCT02814474"]}],"id":[{"id":"10.13039\/100007398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","award":["DSF 0603-00479B"],"award-info":[{"award-number":["DSF 0603-00479B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.bone.2021.116166","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T20:20:09Z","timestamp":1630182009000},"page":"116166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["3-Hydroxybutyrate administration elevates plasma parathyroid hormone in a pilot human randomized, controlled, cross over trial"],"prefix":"10.1016","volume":"153","author":[{"given":"Mads","family":"Svart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars Christian","family":"Gormsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasmus","family":"Espersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaj","family":"Rittig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Starup-Linde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Rejnmark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bone.2021.116166_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190556","article-title":"Regional cerebral effects of ketone body infusion with 3-hydroxybutyrate in humans: reduced glucose uptake, unchanged oxygen consumption and increased blood flow by positron emission tomography. A randomized, controlled trial","volume":"13","author":"Svart","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bone.2021.116166_bb0010","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005066","article-title":"Ketone body infusion with 3-hydroxybutyrate reduces myocardial glucose uptake and increases blood flow in humans: a positron emission tomography study","volume":"6","author":"Gormsen","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bone.2021.116166_bb0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-nutr-071816-064916","article-title":"beta-Hydroxybutyrate: a signaling metabolite","volume":"37","author":"Newman","year":"2017","journal-title":"Annu. Rev. Nutr."},{"issue":"9","key":"10.1016\/j.bone.2021.116166_bb0020","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa370","article-title":"Ketone body, 3-hydroxybutyrate: minor metabolite - major medical manifestations","volume":"105","author":"Moller","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.bone.2021.116166_bb0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/(SICI)1520-7560(199911\/12)15:6<412::AID-DMRR72>3.0.CO;2-8","article-title":"Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes","volume":"15","author":"Laffel","year":"1999","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"10","key":"10.1016\/j.bone.2021.116166_bb0030","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa483","article-title":"Oral D\/L-3-hydroxybutyrate stimulates cholecystokinin and insulin secretion and slows gastric emptying in healthy males","volume":"105","author":"Rittig","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bone.2021.116166_bb0035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1152\/physrev.1980.60.1.143","article-title":"Physiological roles of ketone bodies as substrates and signals in mammalian tissues","volume":"60","author":"Robinson","year":"1980","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.bone.2021.116166_bb0040","first-page":"2503","article-title":"Bone loss and biomechanical reduction of appendicular and axial bones under ketogenic diet in rats","volume":"17","author":"Ding","year":"2019","journal-title":"Exp Ther Med."},{"issue":"6","key":"10.1016\/j.bone.2021.116166_bb0045","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00774-019-01002-2","article-title":"Ketogenic diet compromises vertebral microstructure and biomechanical characteristics in mice","volume":"37","author":"Wu","year":"2019","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2021.116166_bb0050","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3389\/fendo.2019.00880","article-title":"A short-term ketogenic diet impairs markers of bone health in response to exercise","volume":"10","author":"Heikura","year":"2019","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"2","key":"10.1016\/j.bone.2021.116166_bb0055","doi-asserted-by":"crossref","first-page":"e485","DOI":"10.1210\/clinem\/dgaa759","article-title":"Hypercalcemia in children using the ketogenic diet: a multicenter study","volume":"106","author":"Hawkes","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"28","key":"10.1016\/j.bone.2021.116166_bb0060","doi-asserted-by":"crossref","first-page":"8273","DOI":"10.1016\/j.biomaterials.2014.06.020","article-title":"The mechanism of anti-osteoporosis effects of 3-hydroxybutyrate and derivatives under simulated microgravity","volume":"35","author":"Cao","year":"2014","journal-title":"Biomaterials."},{"key":"10.1016\/j.bone.2021.116166_bb0065","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1196\/annals.1402.033","article-title":"Osteoblast and osteoclast differentiation in modeled microgravity","volume":"1116","author":"Saxena","year":"2007","journal-title":"Ann N Y Acad Sci."},{"issue":"8","key":"10.1016\/j.bone.2021.116166_bb0070","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1210\/jc.2015-1884","article-title":"SGLT2 inhibitors may predispose to ketoacidosis","volume":"100","author":"Taylor","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bone.2021.116166_bb0075","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2215\/CJN.04530418","article-title":"Effects of Dapagliflozin on circulating markers of phosphate homeostasis","volume":"14","author":"de Jong","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.bone.2021.116166_bb0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S2213-8587(14)70227-X","article-title":"Possible adverse effects of SGLT2 inhibitors on bone","volume":"3","author":"Taylor","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"8","key":"10.1016\/j.bone.2021.116166_bb0085","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41581-018-0028-0","article-title":"Adverse effects of SGLT2 inhibitors on bone health","volume":"14","author":"Blau","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"issue":"Pt 2","key":"10.1016\/j.bone.2021.116166_bb0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1258\/acb.2007.007091","article-title":"Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference","volume":"45","author":"Roth","year":"2008","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.bone.2021.116166_bb0095","article-title":"Oral 3-hydroxybutyrate ingestion decreases endogenous glucose production, lipolysis, and hormone-sensitive lipase phosphorylation in adipose tissue in men: a human randomized, controlled, crossover trial","volume":"e14","author":"Svart","year":"2020","journal-title":"Diabet. Med."},{"issue":"3","key":"10.1016\/j.bone.2021.116166_bb0100","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.yrtph.2012.04.008","article-title":"Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects","volume":"63","author":"Clarke","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.bone.2021.116166_bb0105","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3389\/fphys.2017.00848","article-title":"On the metabolism of exogenous ketones in humans","volume":"8","author":"Stubbs","year":"2017","journal-title":"Front. Physiol."},{"issue":"8","key":"10.1016\/j.bone.2021.116166_bb0110","doi-asserted-by":"crossref","first-page":"947","DOI":"10.5858\/2002-126-0947-PEOMOI","article-title":"pH effects on measurements of ionized calcium and ionized magnesium in blood","volume":"126","author":"Wang","year":"2002","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"18","key":"10.1016\/j.bone.2021.116166_bb0115","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1113\/jphysiol.2014.273979","article-title":"Regulation of serum phosphate","volume":"592","author":"Lederer","year":"2014","journal-title":"J. Physiol."},{"key":"10.1016\/j.bone.2021.116166_bb0120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1172\/JCI104888","article-title":"Effects of alkalosis on plasma concentration and urinary excretion of inorganic phosphate in man","volume":"43","author":"Mostellar","year":"1964","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.bone.2021.116166_bb0125","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.3945\/ajcn.2008.26099","article-title":"Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet","volume":"88","author":"Bergqvist","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"issue":"22","key":"10.1016\/j.bone.2021.116166_bb0130","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1001\/archinte.166.22.2502","article-title":"Bone mineral density response to caloric restriction-induced weight loss or exercise-induced weight loss: a randomized controlled trial","volume":"166","author":"Villareal","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.bone.2021.116166_bb0135","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/jbmr.2701","article-title":"Effect of two-year caloric restriction on bone metabolism and bone mineral density in non-obese younger adults: a randomized clinical trial","volume":"31","author":"Villareal","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2021.116166_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nutrit\/nuy045","article-title":"Veganism, vegetarianism, bone mineral density, and fracture risk: a systematic review and meta-analysis","volume":"77","author":"Iguacel","year":"2019","journal-title":"Nutr. Rev."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632822100332X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632822100332X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:02:32Z","timestamp":1757613752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S875632822100332X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":28,"alternative-id":["S875632822100332X"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.116166","relation":{},"ISSN":["8756-3282"],"issn-type":[{"type":"print","value":"8756-3282"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3-Hydroxybutyrate administration elevates plasma parathyroid hormone in a pilot human randomized, controlled, cross over trial","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.116166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116166"}}